Lp(a) and Cardiovascular Risk: Advancing Awareness, Testing, and Management in Clinical Practice : Episode 6
Opinion
Video
How the Genetic Nature of Lp(a) Levels Influences Screening
Author(s):
Experts discuss the genetic determinants of lipoprotein(a) (Lp[a]) levels, providing evidence supporting this conclusion. They also explore how the hereditary nature of Lp(a) can drive awareness of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis risk, potentially influencing screening protocols.
Video content above is prompted by the following:
- I mentioned in the introduction that a person’s Lp(a) levels are mostly determined by genetics. What evidence supports this conclusion?
- How might the hereditary nature of Lp(a) help drive awareness of risk for ASCVD and aortic stenosis and influence screening protocols?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Videos
Related Content
